1. Home
  2. SWIN vs BOLD Comparison

SWIN vs BOLD Comparison

Compare SWIN & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • BOLD
  • Stock Information
  • Founded
  • SWIN 2017
  • BOLD 2018
  • Country
  • SWIN Hong Kong
  • BOLD United States
  • Employees
  • SWIN N/A
  • BOLD N/A
  • Industry
  • SWIN
  • BOLD
  • Sector
  • SWIN
  • BOLD
  • Exchange
  • SWIN Nasdaq
  • BOLD Nasdaq
  • Market Cap
  • SWIN 32.1M
  • BOLD 30.3M
  • IPO Year
  • SWIN 2023
  • BOLD 2024
  • Fundamental
  • Price
  • SWIN $3.90
  • BOLD $1.07
  • Analyst Decision
  • SWIN
  • BOLD Buy
  • Analyst Count
  • SWIN 0
  • BOLD 3
  • Target Price
  • SWIN N/A
  • BOLD $4.00
  • AVG Volume (30 Days)
  • SWIN 274.8K
  • BOLD 363.6K
  • Earning Date
  • SWIN 08-21-2025
  • BOLD 08-11-2025
  • Dividend Yield
  • SWIN N/A
  • BOLD N/A
  • EPS Growth
  • SWIN N/A
  • BOLD N/A
  • EPS
  • SWIN N/A
  • BOLD N/A
  • Revenue
  • SWIN $3,316,000.00
  • BOLD N/A
  • Revenue This Year
  • SWIN $29.79
  • BOLD N/A
  • Revenue Next Year
  • SWIN $54.60
  • BOLD N/A
  • P/E Ratio
  • SWIN N/A
  • BOLD N/A
  • Revenue Growth
  • SWIN N/A
  • BOLD N/A
  • 52 Week Low
  • SWIN $1.16
  • BOLD $1.00
  • 52 Week High
  • SWIN $3.92
  • BOLD $4.72
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 83.35
  • BOLD N/A
  • Support Level
  • SWIN $2.88
  • BOLD N/A
  • Resistance Level
  • SWIN $3.48
  • BOLD N/A
  • Average True Range (ATR)
  • SWIN 0.33
  • BOLD 0.00
  • MACD
  • SWIN 0.13
  • BOLD 0.00
  • Stochastic Oscillator
  • SWIN 97.22
  • BOLD 0.00

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: